Good evening, everyone, and thank you for joining us again. As always, we are grateful for the trust you place in us. This call marks a small milestone. Since we listed in November, we have now published four quarterly results. So far, many of you see us as a traditional
eyewear company, good stores, improving EBITDA. That is a fair view of any new listed company. Today, with four quarters behind us, we would like to share the fuller story because what thousands of Lenskartians have spent a decade building is, we believe, one of India's global consumer companies in the making and it deserves to be seen as a whole. That is what our shareholder's letter this quarter attempts, and it is what I want to spend my time on today. First, the quarter. Revenue grew 34% year -on-year and PAT grew 182% to ₹228 crores. One more number for perspective, our PAT for the whole of last year was about ₹530 crores, and PAT for Q1 FY27 is ₹228 crores. Now hold the headline numbers together. A third more revenue has doubled our post-rent EBITDA and nearly tripled our PAT. The compounding is accelerating. Three highlights inside those numbers India same -store sales grew 18.3%, international revenue grew 38%, and consolidated product margin crossed 70% for the first time after four quarters at around 69%. We see our role as creating the market, not competing in it. Every single day now, roughly 35,000 Indians walk into Lenskart stores and discover for the first time in their lives that they cannot see clearly. 63 lakh eye tests in India in this quarter. This number has grown every year, quarter by quarter. Over 1 crore first-time eye tests in FY26. That is not just shifting from one retailer to another. That is a market being born daily, measurably in our stores. Which brings me to the first thing I want you to take away not from this quarter, but from our first year as a public company, that India has not bought its glasses yet. We have written a full section on it in this letter. Let me give you its essence. 78 crore Indians need vision correction today, heading towards 94 crores by FY30. This is not a market to capture, it is a market to build. A year ago, we made a few bets on this market: that every eye test creates a customer and more stores would add dema nd, not divide it, and that Tier 2 plus India was a market waiting to be built. Four quarters on, here is what we have learned about its depth. We grew in three directions. First, we grew deeper. In the last nine months, in our 1,517 existing pin codes, density rose from 1.5 to 1.6 stores, that is about 150 net new stores. Yet, SSSG held at about 18% and same pin code sales growth at 24%. Demand is being added, not divided. B angalore proves it: 189 stores, 13 net additions in the last nine months, mostly in existing pin codes, and still 20% SSSG.
Second, we grew wider. New pin codes in cities we already serve. In Q2 FY26, we shared our existing cities still had 2,821 pin codes without a single Lenskart store. We entered 152 of them. Over 2,650 remain. White space inside cities where our brand, our supply chain, our delivery network are already up and running. On average, revenue per store in these towns is tracking at ₹18 lakhs per month. Take Visakhapatnam, 11 net store additions in nine months, almost half in new pin codes, or Kolkata, 10 net store additions, eight of them in new pin codes. And third, we grew further into towns Lenskart had never entered. 140 of them this year. Hassan in Karnataka, Balasore in Odisha, Tura in Meghalaya, Gandhidham in Gujarat, and many more. These stores are also showing strong unit economics. In nine months, we added 455 net new stores, the fastest expansion in our history, and it consumed about 5% of the 6,400 pin code white space we mapped in our Q2 FY26 letter. Over 6,100 pin codes still await their first Lenskart store, and densification allows for at least another 3,000 stores. India alone points past 10,000 stores now. The map has barely moved, and that is precisely the point. This is a market being built in front of us, and the brand we are building can serve it. Penetration is half the India opportunity; the other half is value. Not just more Indians buying, but each Indian buying better. At one end, premium Owndays lenses are now doing over ₹1,500 crores of prescription eyeglasses sales, and Rodenstock and Tokai eyeglasses, where progressives are priced high -end at ₹30,000 plus, are doing roughly ₹250 crores annually. There is much to build here: India's next iconic premium lens brands. At the same time, on the other end, in the same quarter, we onboarded our largest ever number of customers in the real Bharat through Hustlr Club, which gives ₹500 glasses with lenses and warranty included. Much as India democratized telecom, we intend to democratize vision. The ₹500 and ₹30,000 pair from one platform, and our ambition in India is exactly this: to serve the whole of it, every income, every age, every town. Two confessions along the way: It took us too long to crack the ₹500 pair. The customer was ready, but our costs were not. But now we can do it profitably. And we underestimated how fast our own customers would premiumize. Gladly we were wrong, and we do not intend to repeat either mistake. Coming to International. What we built for India is now beginning to create customer value globally. This quarter, international grew 38%, with EBITDA pre -Ind AS margin crossing 10% for the first time. For four quarters, the most common question investors asked us was, will international be profitable? I believe the question mark is gone. What remains is scale.
Owndays is now one of Asia's most respected eyewear brands, and Meller, which was a USD35 million brand when we acquired it, is tracking to be a $70 million plus brand already. When customers queue on a Paris street for one of our brands, we take it as a signal on how far it can travel. Our aspiration, held with humility, is to build the world's most relevant eyewear company in times to come. And the frontier ahead is even more powerful. This quarter, our self-eye test entered pilot stores, built on one of India's largest recorded eye tes t data sets. Let me show you how we have engineered this.